David Van Houte PhD Regeneron Pharmaceuticals

David received his PhD from Rensselaer Polytechnic Institute and has been in QC Virology with Regeneron Pharmaceuticals since graduating in 2015. David initiated the development of NGS based assays for adventitious agent GMP testing. He now leads a team of 10 researchers continuing the work to modernize QC Virology testing in the GMP space. Currently we are exploring techniques to use the real-time nature of nanopore sequencing to supplement adventitious agent detection assays in an effort to replace traditional compendial methods. Additionally, we are supporting efforts in the cell and gene therapy space to use nanopore sequencing to further characterize AAV drug products.